Tuesday, April 3, 2007

FDA Approves Combination Drug Janumet For Type 2 Diabetes
Article Date: 03 Apr 2007 - 0:00
PDT email this article printer friendly view or write opinions

Article Also Appears In
Pharma Industry

US Food and Drug Administration has approved a new combination drug called Janumet that combines a new drug and an older drug in a more convenient form for people with type 2 diabetes.Janumet is made by Merck & Co and according to the company it is the first and only tablet that combines a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin (also known as Januvia), and metformin for treating patients with type 2 diabetes.Januvia, also made by Merck, enhances the body's own ability to lower elevated blood sugar. It was approved by the FDA last October and received a European Commission licence yesterday. It is mostly taken in combination with other drugs.Metformin is an oral drug in the biguanide class. It is the most widely used drug in the treatment of diabetes in the US and was first made by Bristol-Myers Squibb over ten years ago as Glucophage but has since become available in generic form.Pharma analysts are predicting that Janumet will overtake combination treatments based on Januvia because of its convenient single tablet form.According to Merck's statement, the FDA approved Janumet based "upon clinical data including sitagliptin plus metformin as separate tablets."They say that a clinical bioequivalence study has demonstrated that the single tablet Janumet is equivalent to taking sitagliptin plus metformin as separate tablets.The FDA has approved Janumet as an adjunct to diet and exercise to "improve blood sugar (glucose) control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone, or in patients already being treated with the combination of sitagliptin and metformin".Merck says that Janumet should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.The FDA announced the decision to the press late last Friday.According to the American Diabetes Association more than 6 million Americans have diabetes and don't know it. Another 54 million are pre-diabetic, with an increased risk of having the disease.The ADA give the main risk factors for type 2 diabetes as:-- being overweight-- having a sendentary lifestyle-- being over 45 years old-- having a family history of diabetesAfrican Americans, Latinos, Native Americans, Asian Americans and Pacific Islanders carry an increased risk, as do women who give birth to babies weighing more than nine pounds (4.1 kilos).

Click here to take the ADA diabetes risk test.
Click here for FDA
Written by: Catharine Paddock
Writer: Medical News Today

List of Openings

Here is a list of some of the positions that we are working on right now!

Vice President Regulatory Affairs - Medical Device
Boston MA

Director Regulatory Affairs – Medical Device

Director Regulatory Affairs – Pharmaceuticals
New Jersey

Director Regulatory Affairs – Pharmaceuticals

Senior Director Regulatory Affairs – Pharmaceuticals

Senior Manager Regulatory Affairs, Cell Therapy

Senior Manager Regulatory Affairs - International
New Jersey

Senior Director Regulatory Affairs – Biologic
Hopkinton MA

Senior Manager Regulatory Affairs – Biologic
Hopkinton MA

Sr. Regulatory Affairs Specialist
Several Locations in Massachusetts:
Canton, Beverly, Bedford, Taunton, Davners, Waltham, Hopkinton, Mansfield

~Things are always changing so by the time this is posted something else maybe open or something maybe filled but is you are looking to make a change ~ give us a call and I will be happy to keep you informed as things come up that could be a good next step for you! I have a team of recruiters working for me now and we have a strong presence in the Research Triangle Park Areas as well as the West Coast!


Katie Corliss

Medical Devices

Well if you are a Regulatory Affairs Professional in Massachusetts with Medical Device experience this is your year!

I am working on dozens - yes dozens of jobs, with some great Bay State companies. From the big Fortune 500 device companies that we are all familiar with to some great European companies that are establishing North American Headquarters in MA. This is true the most exciting time I have seen in the medical device field in the past several years. The companies that I am working with are financially stable, growing, investing in their people, and are aggressively pursuing top people.

If you want to learn more feel free to give me a call anytime.

Katie Corliss
Vice President, Life Sciences Practice
207-510-6666 ext 122

Senior Director of Regulatory Affairs - IL

Position Title:
Senior Director Regulatory Affairs
Deerfield, IL
The Director, Global Regulatory Affairs, is responsible for strategic direction of the RA function supporting the Global Business of the Medication Delivery Division for a company with an 80% market share in this space.This is a very key roll with responsibilities for strategic direction and performance of the RA function within multiple portfolios, regions, or business units including development, implementation and management of plans and standards. Accountable for relationship and communication with Regulatory Authorities. Accountable for regulatory strategy and vision across multiple businesses or divisions The position will direct and manage a team of regulatory professionals responsible for development of global regulatory strategic plans for new product development, as well as life cycle management of existing products. Responsibilities include management of all US submissions (INDs, NDAs, SNDAs), in addition to oversight and support for all international registrations. The Director will be accountable for relationship and communication with FDA, as well as business management and international affiliates
.1) Guide, direct, and lead a team of regulatory professionals in development of strategic plans and regulatory submissions
2) Foster and maintain relationships with regulatory authorities to facilitate interactions on behalf of Baxter
3) Ensure alignment of regulatory strategy to business strategy across all functional areas
4) Oversee development and negotiation of overall plans regarding safety, efficacy, and quality to assure viability for global or regional registrations
5) Accountable for ensuring that regulatory submissions meet appropriate standards and content requirements
6) Identify risk areas and develop alternative courses of action including anticipation of regulators responses through scenario planning and development of contingency plans
7) Act as business liaison to the Business Unit, representing Global Regulatory Affairs on the business management team
8) Develop and manage budget as appropriate
9) Act as primary contact with the regulatory authorities including the planning and leadership of meetings

Job Requirements
1. Sound basis of scientific knowledge
2. Expert knowledge of pharmaceutical regulations, standards, current industry practices, and strong experience with interpretation and application.
3. Excellent written and verbal communication, presentation, and facilitation skills
4. Demonstrated leadership skills
5. Proven negotiation skills and significant experience in interacting with regulatory authorities
6. Risk management and problem solving skills
7. Ability to lead, mentor, and develop others for future growth and development8. Demonstrated ability to manage and build relationships with colleagues and regulatory authorities
9. Established credibility with regulatory authorities


Advanced Degree or country equivalent in related scientific discipline with a minimum of 10 years experience in RA, including at least 5 years experience managing people. Higher degree/PhD will be an advantage. International experience/exposure preferred